Startups · AI

Mechanical Engineering Co-Op/Intern (Spring 2027)

Multiply Labs · San Francisco · On-site

← All jobs
About Multiply Labs

Backed by Y Combinator and Lux.

About the role

We are looking for a Mechanical Engineering Co-op/Intern to join our team in San Francisco for a full-time co-op/internship position starting in January 2027. You will apply your engineering skills to design robotic cartridges and consumables involved in the manufacturing of novel pharmaceutical products. Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • Currently working towards a Bachelor of Science in Mechanical Engineering or a related field
  • Strong mechanical fundamentals, creative problem-solving, attention to detail, and communication skills
  • Ability to solve complex technical problems by breaking them down into simpler pieces and executable tasks
  • Experience with 3D CAD software (Onshape, SolidWorks, etc.), including modeling and creation of detailed drawings
  • Knowledge of mechanical components, common engineering metals, plastics, joining methods, part fabrication methods, and finishing operations
  • Understanding of design for manufacturing and assembly (DFM/DFA) principles
More about this role

Multiply Labs is a robotics company on a mission to solve a significant bottleneck in modern medicine: the manufacturing of life-saving advanced biologics, from gene and cell therapies to antibodies and more.

Today, these therapies are produced through manual, labor-intensive processes. Costs are extremely high—often $500K–$2M per patient—limiting access to only a small fraction of those who need them.

As product complexity increases and the cost of failure and scientific labor rises, the industry is shifting toward automation. Robotics and AI are making automated biologics manufacturing feasible, reliable, and economically scalable.

We believe the future of biomanufacturing is robotic—closed, automated, and scalable—ensuring critical therapeutics are accessible to every patient who needs them.

We don’t just build robots—we’re building the essential infrastructure for next-generation biologics. Our technology enables biopharma companies to scale production without redesigning their science, reducing regulatory hurdles and lowering costs so these treatments can reach more patients.

The Mission: Build the world’s best robots to make life-saving therapies accessible to all.

The...

Read the full posting on Multiply Labs's site ↗

Hardware

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.